To view this, you need to install the Flash Player 5. Please go to here and download it.
Breaking News
A Canadian study, published May 14, 2008 in the prestigious New England Journal of Medicine, found that cardiac surgery patients treated with Trasylol were much more likely to die than patients treated with other drugs. The study included over 2,300 patients. Bayer AG, the maker of Trasylol, announced on May 16, 2008 that it will remove the remaining Trasylol stock from the U.S. market. Over 200,000 patients received Trasylol in 2006, which was the peak year for sales. Cardiac surgery patients or their family members who are concerned over these findings are welcome to contact our firm.
Pennsylvania, New York, and New Jersey Trasylol® Side Effects and Lawsuit Information
Trasylol® was approved by the FDA in 1993 for use as a prescription drug to control bleeding during heart surgery. However, in January 2006, the prestigious New England Journal of Medicine concluded that Trasylol® increased the risk of heart attacks, strokes and kidney failure compared to other, similar drugs. An FDA Advisory Committee concluded in September 2006 that Trasylol® was safe and effective for use in certain patients, but it was later learned that Bayer had failed to disclose to the committee the results of an extensive medical study of 67,000 surgery patients, which found the drug's increased risk of heart disease, stroke, kidney failure and death. The revelation that Bayer concealed the unfavorable study results from the FDA prompted the administration to suspend marketing of Trasylol® in November 2007, pending results of an extensive Canadian study of the drug's effects, which is currently underway.
Locks Law Firm is now representing plaintiffs in Trasylol® cases. Our defective drug lawyers are helping victims obtain compensation for their injuries. If you live in Pennsylvania, New York, or New Jersey and have suffered Trasylol® side effects, our experienced attorneys can help you obtain compensation. Contact our personal injury lawyers today; and we will have an experienced attorney at our New Jersey, New York, or Pennsylvania office evaluate your Trasylol® lawsuit.
About Trasylol®
Trasylol®, also known as aprotinin injection, was developed by Bayer and widely used on surgery patients across the nation following its FDA approval in 1993. Sales of the drug reached $135 million in the first nine months of 2007 alone and nearly five million Americans were exposed to the drug since 1993, including 110,000 in 2006. Most patients were exposed to Trasylol® during coronary bypass and open-heart surgery, but some patients may not be aware that the drug was used during their procedures. If you were treated with Trasylol® during a surgical procedure, you may have a valid legal claim against the manufacturer. Contact the Locks Law offices serving Pennsylvania, New York, and New Jersey to learn more about Trasylol® side effects and discuss your potential Trasylol® lawsuit.
Trasylol® Side Effects
The primary side effects of Trasylol® include serious kidney damage, heart attack and stroke. Studies of the drug have concluded that as many as 22,000 Trasylol® patients died unnecessarily because of the drug and could have been saved if Bayer had pulled the product in January 2006, when scientific articles began detailing widespread complications from its use. If you or a loved one had coronary bypass surgery or open heart surgery and have suffered kidney damage, heart damage or stroke, Trasylol® may have been given during the procedure, perhaps without the patient's knowledge.
Trasylol® Lawsuit
At the Locks Law Firm, our dangerous drug attorneys are experienced and aggressive. We can help you file a Trasylol® lawsuit if you have suffered serious side effects from the drug. We have handled many pharmaceutical litigation claims and have obtained millions of dollars in verdicts and settlements on behalf of our clients. With extensive experience in this complex area of law, your attorney will not be afraid to stand up to big pharmaceutical companies like Bayer. Contact our Pennsylvania, New York, and New Jersey offices to schedule a Trasylol® lawsuit consultation.
Contact a Trasylol® Lawyer
The Locks Law Firm is presently investigating legal claims on behalf of Pennsylvania, New York, or New Jersey clients injured by Trasylol® side effects. If you or a loved one has been injured, we invite you to contact us for a free, confidential Trasylol® lawsuit consultation. We will carefully evaluate your case and explain your legal options.
If you would like to schedule a free consultation with a New Jersey, New York or Pennsylvania VIOXX® and Bextra® lawyer, contact Locks Law today.
